Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  New England Journal of Medicine

• Publication date

  1993-04-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199304223281605PMID 8455683
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HIV-1 sensitivity to zidovudine and clinical outcome in children.

  1992cited by this paper
• Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine

  1992cited by this paper
• Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.

  1992cited by this paper
• Sensitive microculture method for isolation of human immunodeficiency virus type 1 from blood leukocytes

  1992cited by this paper
• Susceptibility of HIV-1 isolates to zidovudine: correlation between widely applicable culture test and PCR analysis.

  1992cited by this paper
• Characterization of HIV Isolates Arising After Prolonged Zidovudine Therapy

  1992cited by this paper
• In Vivo Prevalence of Azidothymidine (AZT) Resistance Mutations in an AIDS Patient Before and After AZT Therapy

  1991cited by this paper
• Detection of human immunodeficiency virus type 1 clinical isolates with reduced sensitivity to zidovudine and dideoxyinosine by RNA.RNA hybridization.

  1991cited by this paper
• Zidovudine in the management of primary HIV‐1 infection

  1991cited by this paper
• Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase.

  1991cited by this paper
• Inhibition of immune functions by antiviral drugs.

  1991cited by this paper
• High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.

  1991cited by this paper
• Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.

  1991cited by this paper
• Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus.

  1990cited by this paper
• HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.

  1989cited by this paper
• Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).

  1989cited by this paper

• SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs.

  2024cites this paper
• Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog-Associated Mutations and M184V

  2020cites this paper
• In silico studies on new oxathiadiazoles as potential anti-HIV agents

  2019cites this paper
• Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden

  2018cites this paper
• Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment–Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide

  2017cites this paper
• HIV drug resistance in HIV positive individuals under antiretroviral treatment in Shandong Province, China

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Broad spectrum of in vivo fitness of human immunodeficiency virus type I subpopulations differing at reverse transcriptase codons 41 and 215

  2017cites this paper
• Analysis of transmitted HIV drug resistance from 2005 to 2015 in Victoria, Australia: a comparison of the old and the new.

  2017cites this paper
• Transmitted drug resistance mutations and subtype diversity among HIV-1 sero-positive voluntary blood donors in Accra, Ghana

  2017cites this paper
• Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort study

  2016cites this paper
• Incidence and Factors Associated with the Switch to the Second Line Antiretroviral Treatment at the Ambulatory Treatment Center (CTA) in Dakar

  2016cites this paper
• Transmission of HIV-1 Drug Resistance

  2015cites this paper
• Pharmacokinetic Modeling of Lamivudine and Zidovudine Triphosphates Predicts Differential Pharmacokinetics in Seminal Mononuclear Cells and Peripheral Blood Mononuclear Cells

  2015cites this paper
• Clinical and laboratory features of HIV/AIDS in the Kingdom of Saudi Arabia

  2015cites this paper
• Tools and applications for DNA sequencing in the clinical management of viral infectious diseases : examples from HIV-1 and HCV

  2015cites this paper
• Development and Customization of a Color-Coded Microbeads-Based Assay for Drug Resistance in HIV-1 Reverse Transcriptase

  2014cites this paper
• The dynamics of local hiv-1 epidemics: the colombian and belgian cohorts

  2014influential citation
• Community HIV‐1 drug resistance is associated with transmitted drug resistance

  2014cites this paper
• Acyclic nucleoside phosphonates: a study on cytochrome P450 gene expression

  2014cites this paper
• Проблема резистентности вируса иммунодефицита человека к антиретровирусным препаратам

  2014cites this paper
• The mechanism of action of iminosugars as antiretrovirals

  2014cites this paper
• An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

  2014cites this paper
• Investigating the development and evolution of drug resistance in the HIV-1 pol gene

  2013cites this paper
• Manifestações bucais da AIDS e o perfil de mutações e de resistência do HIV em pacientes experimentando falha terapêutica

  2013cites this paper
• HIV-1 ÜLEKANDUVA RAVIMRESISTENTSUSE ESINEMINE 2010. AASTAL HIV-DIAGNOOSI SAANUD ISIKUTEL EESTIS

  2013cites this paper
• Decreasing trends of drug resistance and increase of non-B subtypes amongst subjects recently diagnosed as HIV-infected over the period 2004-2012 in the Veneto Region, Italy.

  2013cites this paper
• HIV-1 transmitted drug resistance in Latin America and the Caribbean: what do we know?

  2012cites this paper
• Zidovudine

  2012cites this paper
• The Dual Role of Pharmacogenetics in HIV Treatment: Mutations and Polymorphisms Regulating Antiretroviral Drug Resistance and Disposition

  2012cites this paper
• PRIMARY HIV-1 RESISTANCE - PERSISTENCE OF TRANSMITTED DRUG RESISTANCE MUTATIONS

  2012cites this paper
• Mutaciones asociadas a resistencia a fármacos antirretrovirales en una población penitenciaria «Naïve»

  2012cites this paper
• The Epidemiology of HIV-1 Transmitted Drug Resistance

  2012cites this paper
• HIV-1 Resistenzentwicklung nach Einsatz antiretroviraler Medikamentenregime zur Prävention der Mutter-Kind-Übertragung von HIV in Uganda und Tansania

  2012cites this paper
• Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease.

  2011cites this paper
• Article Commentary: Transmitted Resistance to HIV Integrase Strand-Transfer Inhibitors: Right on Schedule

  2011cites this paper
• Transmission of Integrase Strand-Transfer Inhibitor Multidrug-Resistant HIV-1: Case Report and Response to Raltegravir-Containing Antiretroviral Therapy

  2011cites this paper
• HIV Recombination and Pathogenesis – Biological and Epidemiological Implications

  2011cites this paper
• HIV-1 drug resistance and molecular epidemiology in Honduras

  2011cites this paper
• HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study.

  2011cites this paper
• Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras.

  2010cites this paper
• Characterization of HIV-1 pol sequences in newly HIV-1 diagnosed patients: identification of drug resistance markers and their involvement in the transmission events

  2010cites this paper
• Minority variants of drug-resistant HIV.

  2010cites this paper
• Resistencia Primaria de HIV-1: estado de situación en Argentina: [revisión]

  2010cites this paper
• Prevalence of minor variants of HIV strains at reverse transcriptase position 103 in therapy-naïve patients and their impact on the virological failure.

  2009cites this paper
• Monitoring HIV drug resistance in treatment-naive individuals: molecular indicators, epidemiology and clinical implications.

  2009cites this paper
• Understanding transmitted HIV resistance through the experience in the USA.

  2009cites this paper
• Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection.

  2009cites this paper
• Primary Antiretroviral Drug Resistance among HIV Type 1-Infected Individuals in Brazil

  2009cites this paper
• Clinical Implications of HIV-1 Drug Resistance

  2009cites this paper
• Patrones de prescripción de antirretrovirales en 997 pacientes colombianos

  2008cites this paper
• Sexual networks and the transmission of drug-resistant HIV

  2008cites this paper
• Drug-Resistance Mutations Number and K70R or T215Y/F Substitutions Predict Treatment Resumption during Guided Treatment Interruptions

  2008cites this paper
• [Patterns of antiretroviral drug prescription in 997 Colombian patients].

  2008cites this paper
• [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].

  2007cites this paper
• Combined therapy for tuberculosis and HIV-1: the challenge for drug discovery.

  2007cites this paper
• Antiretroviral (ARV) drug resistance in the developing world.

  2007cites this paper
• Trends of prevalence of primary HIV drug resistance in Germany.

  2007cites this paper
• Transmitted Resistance: An Overview and Its Potential Relevance to the Management of HIV-Infected Persons in Resource-Limited Settings

  2007cites this paper
• Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection

  2007cites this paper
• The Epidemiology of Transmission of Drug Resistant HIV-1

  2007cites this paper
• Avaliação da resistência do HIV-1 às drogas anti- retrovirais em 150 pacientes em interrupção terapêutica por mais de seis meses

  2007cites this paper
• Molecular diagnosis of medical viruses.

  2007cites this paper
• Anti‐retroviral drug resistance‐associated mutations among non‐subtype B HIV‐1‐infected Kenyan children with treatment failure

  2007cites this paper
• Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance.

  2007cites this paper
• Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection.

  2007cites this paper
• Epidemiologie der primären Medikamentenresistenz bei chronisch HIV-Infizierten in Nordrhein-Westfalen 2001-2005

  2007cites this paper
• Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection.

  2007cites this paper
• HIV transmission and primary drug resistance.

  2006cites this paper
• HIV-1 reverse transcriptase: a therapeutical target in the spotlight.

  2006cites this paper
• Treatment switch guided by HIV-1 genotyping in Brazil.

  2006cites this paper
• Overview of HIV drug resistance and its implications for China

  2006cites this paper
• Patterns of Resistance to Antiretroviral Therapy among HIV+ Patients in Clinical Care

  2006cites this paper
• Primary HIV Drug Resistance and Efficacy of First-Line Antiretroviral Therapy Guided by Resistance Testing

  2006cites this paper
• Correlation of a Brief Perceived Stress Measure With Nonadherence to Antiretroviral Therapy Over Time

  2005cites this paper
• Prevalence of Transmitted HIV-1 Drug Resistance and the Role of Resistance Algorithms: Data From Seroconverters in the CASCADE Collaboration From 1987 to 2003

  2005cites this paper
• Cyclic Sulfamide HIV-1 Protease Inhibitors : Design, Synthesis and Modelling

  2005cites this paper
• Detection of minor populations of drug-resistant HIV-1 in acute seroconverters

  2005cites this paper
• Snapshot of HIV pathogenesis in China

  2005cites this paper
• Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.

  2005cites this paper
• HIV treatment decisions and transmitted drug resistance.

  2005cites this paper
• HIV/AIDS in 2004: the epidemiologist's point of view

  2005cites this paper
• Confronting the Emergence of Drug-Resistant HIV Type 1: Impact of Antiretroviral Therapy on Individual and Population Resistance

  2005cites this paper
• A comparison of dyslipidemias associated with either lopinavir/ritonavir- or indinavir/ritonavir-based antiretroviral therapy.

  2004cites this paper
• Drug resistance in non-subtype B HIV-1.

  2004cites this paper
• Primary HIV infection

  2004cites this paper
• Viruses in semen and male genital tissues--consequences for the reproductive system and therapeutic perspectives.

  2004cites this paper
• Transmitted Human Immunodeficiency Virus Type 1 Carrying the D67N or K219Q/E Mutation Evolves Rapidly to Zidovudine Resistance In Vitro and Shows a High Replicative Fitness in the Presence of Zidovudine

  2004cites this paper
• HIV drug resistance.

  2004cites this paper
• HIV drug resistance.

  2004cites this paper
• Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in Germany.

  2004cites this paper
• The role of baseline HIV-1 resistance testing in patients with established infection

  2004cites this paper
• Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.

  2004cites this paper
• High resistance to antiretroviral drugs: the Indian experience

  2004cites this paper
• Chapter 3 – The Genetic Diversity and Global Molecular Epidemiology of HIV

  2004cites this paper
• Detection of antiretroviral resistance in HIV-1.

  2003cites this paper
• Worldwide transmission of drug-resistant HIV.

  2003cites this paper
• Guidance for the Clinician in Rendering Pediatric Care

  2003cites this paper
• Genotypic Resistance of Antiretroviral Drugs among Drug-Naive HIV Type 1 Patients with the Background of Long-Term Access-Easy Zidovudine Therapy

  2003cites this paper
• Resistenz in der antiretroviralen Therapie der HIV-Infektion*

  2003cites this paper
• [Drug resistance in antiretroviral therapy of HIV infection].

  2003cites this paper